A detailed history of Nuveen Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 9,509,371 shares of ABBV stock, worth $1.62 Billion. This represents 0.54% of its overall portfolio holdings.

Number of Shares
9,509,371
Previous 9,610,467 1.05%
Holding current value
$1.62 Billion
Previous $1.65 Billion 13.92%
% of portfolio
0.54%
Previous 0.49%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $16.6 Million - $20.2 Million
-101,096 Reduced 1.05%
9,509,371 $1.88 Billion
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $112 Million - $131 Million
723,838 Added 8.15%
9,610,467 $1.65 Billion
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $35.3 Million - $40.2 Million
-220,600 Reduced 2.42%
8,886,629 $1.62 Billion
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $185 Million - $209 Million
-1,345,476 Reduced 12.87%
9,107,229 $1.41 Billion
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $66.1 Million - $76.6 Million
-495,010 Reduced 4.52%
10,452,705 $1.56 Billion
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $56.8 Million - $70.6 Million
-428,384 Reduced 3.77%
10,947,715 $1.47 Billion
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $141 Million - $163 Million
-977,479 Reduced 7.91%
11,376,099 $1.81 Billion
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $168 Million - $201 Million
-1,212,368 Reduced 8.94%
12,353,578 $2 Billion
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $151 Million - $173 Million
-1,124,828 Reduced 7.66%
13,565,946 $1.82 Billion
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $234 Million - $298 Million
-1,701,065 Reduced 10.38%
14,690,774 $2.25 Billion
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $7.93 Million - $9.84 Million
60,090 Added 0.37%
16,391,839 $2.62 Billion
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $186 Million - $235 Million
1,727,890 Added 11.83%
16,331,749 $2.21 Billion
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $74.9 Million - $85 Million
-704,102 Reduced 4.6%
14,603,859 $1.58 Billion
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $211 Million - $235 Million
-2,007,205 Reduced 11.59%
15,307,961 $1.72 Billion
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $2 Million - $2.2 Million
19,506 Added 0.11%
17,315,166 $1.87 Billion
Q4 2020

May 17, 2021

BUY
$80.49 - $108.67 $62.4 Million - $84.2 Million
775,186 Added 4.69%
17,295,660 $1.85 Billion
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $289 Million - $390 Million
-3,592,348 Reduced 17.86%
16,520,474 $1.77 Billion
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $173 Million - $203 Million
-2,011,667 Reduced 9.09%
20,112,822 $1.76 Billion
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $510 Million - $683 Million
6,956,787 Added 45.87%
22,124,489 $2.17 Billion
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $137 Million - $208 Million
2,126,043 Added 16.3%
15,167,702 $1.16 Billion
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $187 Million - $234 Million
2,592,492 Added 24.81%
13,041,659 $1.15 Billion
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $53.9 Million - $64.8 Million
855,322 Added 8.92%
10,449,167 $791 Million
Q2 2019

Aug 15, 2019

BUY
$65.7 - $83.98 $596 Million - $761 Million
9,065,487 Added 1715.78%
9,593,845 $698 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $2.41 Million - $2.84 Million
-31,240 Reduced 5.58%
528,358 $42.6 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $13.5 Million - $16.7 Million
173,898 Added 45.09%
559,598 $51.6 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $10.3 Million - $11.4 Million
115,585 Added 42.79%
385,700 $36.5 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $470,088 - $556,220
5,236 Added 1.98%
270,115 $25 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $28.9 Million - $38.7 Million
-314,312 Reduced 54.27%
264,879 $25.1 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $7.15 Million - $7.84 Million
-79,796 Reduced 12.11%
579,191 $0
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $46 Million - $58.8 Million
658,987
658,987 $58.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.